New Stem Cell Method Could Advance Research Into Spinal Muscular Atrophy @checkrare
New Stem Cell Method Could Advance Research Into Spinal Muscular Atrophy  @checkrare
Uploaded October 2026 | Updated November 2026, 16 hours ago
Kyle Loh, PhD, Associate Professor at Stanford Medicine, discusses research that could help scientists better understand spinal muscular atrophy (SMA) by generating new motor neurons from human hindbrain cells in the laboratory.    

SMA is a genetic neuromuscular disorder characterized by the loss of motor neurons, causing progressive muscle weakness and loss of movement due to atrophy. SMA mainly affects the muscles involved in walking, sitting, arm movement, and head control. Breathing and swallowing may also become difficult as the disease progresses. SMA is caused by genetic mutations in the SMN1 gene. Extra copies of the nearby related gene, SMN2, modify the severity of SMA, with type 1 being the most severe and type 4 the least severe. 

The study by Dr. Loh and his colleagues examined how different parts of the brain develop and use that knowledge to create new ways to generate new cells, including motor neurons. While the brain is often viewed as a single organ originating from one source, it is actually built from two distinct sources: one creating the forebrain/midbrain and another creating the hindbrain. As Dr. Loh explains, this distinction is critical for understanding the evolution of the brain and for developing human neurons in a laboratory setting.

Neurons in the hindbrain have received less attention than the well-studied spinal cord motor neurons. However, these hindbrain neurons are essential for life-sustaining functions, including eating, swallowing, speech, and facial movements. To study these neurons, specific genes that mark different progenitor cells were identified: OTX2 for forebrain/midbrain and GBX2 for the hindbrain. By directing stem cells toward these specific progenitor states, hindbrain motor neurons can be generated in a petri dish.

This study includes the creation of human induced pluripotent stem cell lines from patients with type 1 SMA to observe how the condition affects the growth of hindbrain motor neurons.

Dr. Loh is also interested in exploring the pathophysiology of SMA further. For example, the SMN1 gene is ubiquitously expressed in every cell in the body, its loss specifically impacts a small subset of motor neurons in patients with SMA. Further work is also needed to investigate why certain motor neurons, such as those innervating the diaphragm, appear resilient in  patients with SMA while muscles nearby are impacted. Understanding this natural resilience could offer a new approach to therapy that moves beyond simply replacing the missing gene.

For more information, visit nature.com/articles/s41593-026-02433-7

To learn more about SMA and other rare neurological conditions, visit checkrare.com/diseases/neurology-nervous-system-diseases

Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.
New Stem Cell Method Could Advance Research Into Spinal Muscular AtrophyImprovements in Mobility in Patients Treated with Miv-Cel with Stiff Person SyndromeUCB Study Highlights the Burden of Ocular Myasthenia GravisNarcolepsy Diagnosis and Symptoms: Understanding the Daily Burden of the DiseaseLiving With Ocular Symptoms of Myasthenia GravisNew Graves’ Disease Community WebsiteFDA Approves Multiple Myeloma Drug;  FDA Denies Neuroendocrine Drug; Safety Concerns For Prader-W...FDA CDER’s Accelerating Rare Disease Cures ProgramSeronegative Myasthenia Gravis Targeted Therapy SelectionFDA Approves New Narcolepsy Treatment | The CheckRare BriefHow Bispecific Antibodies Are Changing Multiple Myeloma Treatment
CheckRare |

New Stem Cell Method Could Advance Research Into Spinal Muscular Atrophy

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER